BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:MET-233i readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of MET-233i\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07725809-180@assetmemo.bio
DTSTAMP:20261121T005650Z
DTSTART;VALUE=DATE:20270113
DTEND;VALUE=DATE:20270114
SUMMARY:MET-233i: Phase 1 readout est. (NCT07725809)
DESCRIPTION:MET-233i\, phase 1\, Obesity.\nStudy: A Study to Learn How the 
 Study Medicine Called PF-08653945 is Taken up Into the Blood in Adults Wit
 h Overweight or Obesity\nEstimated primary completion: 13 January 2027. Th
 is is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and i
 t can move.\nDrug page: https://assetmemo.bio/drug/met-233i#upcoming-event
 s\nRegistry record: https://clinicaltrials.gov/study/NCT07725809
URL:https://assetmemo.bio/drug/met-233i#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07575932-180@assetmemo.bio
DTSTAMP:20261121T005650Z
DTSTART;VALUE=DATE:20270804
DTEND;VALUE=DATE:20270805
SUMMARY:MET-233i: Phase 2 readout est. (NCT07575932)
DESCRIPTION:MET-233i\, phase 2\, Obesity.\nStudy: A Study of PF-08653945 an
 d PF-08653944 in Adults With Overweight or Obesity\nEstimated primary comp
 letion: 4 August 2027. This is a ClinicalTrials.gov estimate\, not a confi
 rmed readout date\, and it can move.\nDrug page: https://assetmemo.bio/dru
 g/met-233i#upcoming-events\nRegistry record: https://clinicaltrials.gov/st
 udy/NCT07575932
URL:https://assetmemo.bio/drug/met-233i#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
